Relaying what matters next.

The Relay is a new media project dedicated to covering slightly futuristic domains such as artificial intelligence, space exploration, longevity science, crypto and blockchain, advanced biology, and defense technologies. Our mission is to capture the signals of tomorrow and relay them forward with clarity, depth, and context.

What's happening today?

AI islands collide with Texas’s new 765 kV power superhighway

AI islands collide with Texas’s new 765 kV power superhighway

AI data centers are racing into the Permian on islanded gas-plus-battery microgrids while Texas readies 765 kV lines to move bulk ERCOT power west. SB 6 rewrites who pays, how to connect, and when operators must curtail.

Euclid’s first sky map opens the dark universe to all

Euclid’s first sky map opens the dark universe to all

On March 19, 2025, ESA's Euclid released Quick Data Release 1, a deep sampler of images, spectra, and catalogs. We unpack what is in Q1, how to access it, early science highlights, and what to watch before DR1 in 2026.

Ammo Factories Go to War: The 155mm Surge’s New Chokepoints

Ammo Factories Go to War: The 155mm Surge’s New Chokepoints

Spring to summer 2025 delivered new U.S. LAP lines and a greenlit Iowa complex, plus fresh European spend. Yet chemistry and small energetics now cap the rate. We map the real chokepoints, why six figures a month slips to mid 2026, and what sustained mass fires mean for doctrine and the Pacific.

America’s LNG Reboot: DOE ends pause, Gulf projects sprint

America’s LNG Reboot: DOE ends pause, Gulf projects sprint

The Department of Energy restored LNG approvals in January 2025, clearing a backlog and jump-starting Gulf Coast projects. We break down who advanced, what volumes are realistic for 2026 to 2030, and which bottlenecks like pipelines, labor and methane rules could still slow the surge.

GLP-1s at the 2025 inflection: from weight loss to healthspan

GLP-1s at the 2025 inflection: from weight loss to healthspan

Outcomes data and payer shifts have turned GLP-1s into a population health tool. Here is the biology, the care models, and the metrics that turn pounds into years lived better.

JUICE’s hot Venus slingshot and the near-miss timer bug

JUICE’s hot Venus slingshot and the near-miss timer bug

In late August 2025 ESA’s JUICE skimmed past Venus for a high-heat gravity assist while controllers beat a last-minute comms glitch traced to a software timer. Why cameras stayed off, how the team kept the spacecraft cool, and what this flyby sets up next.

At Zoomtopia 2025, AI Companion 3.0 goes cross-platform

At Zoomtopia 2025, AI Companion 3.0 goes cross-platform

Zoom’s AI Companion 3.0 debuts as a low code, cross platform agent that follows you into Teams and Google Meet, automates follow through, and brings enterprise controls. Here is why bring your own agent matters, how it changes Monday workflows, and the questions to ask before you buy.

From Ghost Shark to Swarms: How XL-AUVs Scale to War

From Ghost Shark to Swarms: How XL-AUVs Scale to War

Australia just locked in a Ghost Shark fleet, signaling that extra‑large autonomous subs are moving from prototypes to massed systems. The shift will reshape anti‑submarine warfare, seabed security, and coalition kill chains across AUKUS.

MiCA’s Passporting Showdown Tests Europe’s Unity

MiCA’s Passporting Showdown Tests Europe’s Unity

France and allies just challenged MiCA’s single license promise, hinting at passport vetoes and a push to shift big‑firm oversight to ESMA. We map the legal mechanics, three scenarios, near‑term risks, and how a tightening UK and US corridor could siphon activity.

How 2025 locked in the West’s two-track day-ahead market

How 2025 locked in the West’s two-track day-ahead market

In 2025, CAISO’s EDAM and SPP’s Markets+ moved from debate to buildout. Here is who joins when, how the seam will work, and what changes by 2026 to 2028.

Senolytics hit the clinic: three 2025 trials define the turn

Senolytics hit the clinic: three 2025 trials define the turn

Three credible trials are dragging senolytics out of mouse lore and into human data. St. Jude pits dasatinib plus quercetin against fisetin, Washington University runs SToMP-AD in early Alzheimer’s, and NIH backs a frailty study in people aging with HIV. Intermittent pulse dosing, functional endpoints like gait speed, and on-target biomarkers could make 2025 the pivot year.

IMAP to L1: The mission to map the heliosphere’s edge

IMAP to L1: The mission to map the heliosphere’s edge

With Solar Cycle 25 surging, NASA’s IMAP heads for the Sun-Earth L1 point to image the heliosphere in 3D while SWFO‑L1 delivers earlier, more reliable space weather alerts.

ChatGPT’s Agent Goes Cloud‑Scale, And Work Will Follow

ChatGPT’s Agent Goes Cloud‑Scale, And Work Will Follow

OpenAI has folded its Operator browser agent into ChatGPT and is steering the stack toward supervised cloud workers. Here is what cloud‑scale agents mean for SaaS vendors, enterprise IT, and developers, plus a practical checklist to get ready.

Typhon Comes Ashore: Japan Debut Rewrites the First Island Chain

Typhon Comes Ashore: Japan Debut Rewrites the First Island Chain

On September 15 the U.S. Army brought its Typhon mid range missile system to MCAS Iwakuni for Resolute Dragon, putting land based SM 6 and Tomahawk options back inside the First Island Chain. The short stay signals a durable shift in Indo Pacific deterrence rather than a one off showcase.

Telegram brings TON Wallet to the U.S., a new web3 onramp

Telegram brings TON Wallet to the U.S., a new web3 onramp

Telegram is rolling out a self-custodial TON Wallet for U.S. users, bringing USDT payments, swaps, and mini-apps into the chat interface. Here is what it unlocks for payments, games, and developers.

Who Connects First Now: PJM, MISO and CAISO’s Fast Tracks

Who Connects First Now: PJM, MISO and CAISO’s Fast Tracks

U.S. grid operators just opened express lanes for near‑term megawatts. We break down which PJM, MISO and CAISO projects can realistically hit 2027 to 2029 CODs, how PJM’s record capacity prices tilt technology choices, and the moves developers, LSEs and data centers should make now.

Dogs First: FDA nod makes canines the longevity testbed

Dogs First: FDA nod makes canines the longevity testbed

With the FDA’s first efficacy green light for a canine anti aging pill and a revived NIH backed rapamycin trial, companion dogs are becoming the de risked bridge to human geroprotectors. Here is the biology, the regulatory playbook, and what to watch next.

Juno catches Io's most powerful eruption, models shift

Juno catches Io's most powerful eruption, models shift

NASA confirmed on January 28, 2025 that Juno’s December 27, 2024 flyby of Io recorded the moon’s most energetic volcanic outburst yet. A giant southern hotspot and nearby sites brightened together, pointing to connected magma reservoirs and a rethink of how tidal heating works.